Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion. Pan Y, Liu X, Zhang W, Wang W, et al. Lung Cancer 2023;181:107233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pan Y, Liu X, Zhang W, Wang W, et al. Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion. Lung Cancer 2023;181:107233.
PMID: 37201296